FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications - FDA Press Releases

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

from Food and Drug Administration--Press Releases https://ift.tt/2GdPmnI
via IFTTT